Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd. financial statements

Altamira Therapeutics Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2024

RevenueUSD 0EODHD
Net income−USD 8.46M20-F
Cash and equivalentsUSD 998.62K6-K

Altamira Therapeutics Ltd. financials on 6ix · Altamira Therapeutics Ltd. on 6ix